Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $139.90M.
ENTERPRISE VALUE (EV)
$139.90M
Codexis, Inc.
Market Cap
$150.59M
Enterprise Value (EV)
$139.90M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Codexis, Inc. (CDXS) | $150.59M | $139.90M |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | $133.87M |
| Immuneering Corporation (IMRX)vs › | $146.66M | $108.97M |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | $34.12M |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | $125.97M |
| Korsana Biosciences, Inc. (KRSA)vs › | $143.81M | $142.42M |
| LifeMD, Inc. (LFMDP)vs › | $155.88M | $136.75M |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | $10.70M |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | $100.73M |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.26M | $133.21M |
Market Cap
$150.59M
Total Debt
$40.10M
Cash
$50.79M
Enterprise Value
$139.90M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
